vTv Therapeutics to Present at the 30th Annual Piper Jaffray Healthcare Conference
HIGH POINT, N.C.--(BUSINESS WIRE)--Nov 19, 2018--vTv Therapeutics Inc. (Nasdaq: VTVT) today announced that company management will present a corporate overview at the Piper Jaffray 30 th Annual Healthcare Conference on Tuesday, Nov. 27, 2018 at 2:10 p.m. ET in New York City.
vTv Therapeutics is a clinical-stage biopharmaceutical company engaged in the discovery and development of orally administered small molecule drug candidates to fill significant unmet medical needs. vTv has a pipeline of clinical drug candidates led by programs for the treatment of Alzheimer’s disease and diabetes as well as treatment of inflammatory disorders.
View source version on businesswire.com:https://www.businesswire.com/news/home/20181119005483/en/
vTv Therapeutics Inc.
KEYWORD: UNITED STATES NORTH AMERICA NEW YORK NORTH CAROLINA
INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY CLINICAL TRIALS MENTAL HEALTH PHARMACEUTICAL DIABETES
SOURCE: vTv Therapeutics Inc.
Copyright Business Wire 2018.
PUB: 11/19/2018 04:00 PM/DISC: 11/19/2018 04:01 PM